Measurement of the rates of synthesis of three components of ribosomes of Mycobacterium fortuitum: a theoretical approach to qRT-PCR experimentation.

PloS One
Maria Jesus GarciaRobert Ashley Cox

Abstract

Except for the ribosomal protein L12 (rplL), ribosomal proteins are present as one copy per ribosome; L12 (rplL) is unusual because it is present as four copies per ribosome. Thus, the strategies used by Mycobacterium fortuitum to regulate ribosomal protein synthesis were investigated, including evaluations of the rates of chain elongations of 16S rRNA, rplL and ribosomal protein S12 (rpsL). RNA was isolated from cell cultures and cDNA was prepared. The numbers of cDNA copies of 16S rRNA, precursor-16S rRNA and transcripts of rpsL and rplL were quantified by qRT-PCR and then related to the rates of 16S rRNA, rpsL and rplL chain elongations by means of a mathematical framework for coupled transcription/translation. The rates of synthesis of 16S rRNA, rpsL and rplL respectively were found to be approximately 50 x 10(3) nucleotides h(-1), 1.6 x 10(3) amino acid residues h(-1) and 3.4 x 10(3) amino acid residues h(-1). The number of transcripts of rplL was approximately twice that of rpsL. These data account for the presence of one copy of rpsL and four copies of rplL per ribosome, and reveal that the rate of M. fortuitum ribosome synthesis was closer to that of M. tuberculosis than to E. coli. Except for rplJ, the elongation rate ...Continue Reading

References

Feb 1, 1977·Journal of Bacteriology·R M Harshey, T Ramakrishnan
Oct 11, 1991·Journal of Bacteriology·S L GottaS L French
Apr 20, 1987·Journal of Molecular Biology·W L Downing, P P Dennis
Jul 24, 1970·Science·O L MillerC A Thomas
Feb 1, 1966·The Biochemical Journal·V G Malathi, T Ramakrishnan
Jan 1, 1984·Annual Review of Biochemistry·M NomuraG Baughman
May 1, 1994·Journal of Bacteriology·U Vogel, K F Jensen
Jan 1, 1994·Progress in Nucleic Acid Research and Molecular Biology·J M Zengel, L Lindahl
Jun 1, 1996·Human Molecular Genetics·F TamaniniA T Hoogeveen
Jan 1, 1996·Growth Factors·S KleinD B Rifkin
Nov 26, 1997·Journal of Bacteriology·J A Gonzalez-y-MerchandR A Cox
Dec 22, 1999·The Proceedings of the Nutrition Society·P Ferré
Oct 9, 2002·Current Protein & Peptide Science·Markus C Wahl, Wim Möller
Jul 1, 1964·Proceedings of the National Academy of Sciences of the United States of America·R BYRNEM W NIRENBERG
Oct 22, 2003·Proceedings of the National Academy of Sciences of the United States of America·Christopher M Sassetti, Eric J Rubin
Dec 1, 2004·Annual Review of Genetics·Brian J PaulRichard L Gourse
Nov 1, 2005·Critical Reviews in Biochemistry and Molecular Biology·Daniel N Wilson, Knud H Nierhaus
May 17, 2007·Current Molecular Medicine·Robert A Cox, Gregory M Cook

❮ Previous
Next ❯

Datasets Mentioned

BETA
X99775

Methods Mentioned

BETA
electrophoresis
electron microscopy
PCR

Related Concepts

Related Feeds

Bacterial Protein Structures

Bacterial protein structures can expedite the development of novel antibiotics. Here is the latest research on bacterial proteins and the resolution of their structures.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.